Amyloid proteins and peptides comprise a diverse group of molecules that vary both in size and amino-acid sequence, yet assemble into amyloid fibrils that have a common core structure. Kinetic studies of amyloid fibrillogenesis have revealed that certain amyloid proteins form oligomeric intermediates prior to fibril formation. We have investigated fibril formation with a peptide corresponding to residues 195-213 of the human prion protein. Through a combination of kinetic and equilibrium studies, we have found that the fibrillogenesis of this peptide proceeds as an all-or-none reaction where oligomeric intermediates are not stably populated. This variation in whether oligomeric intermediates are stably populated during fibril formation indicates that amyloid proteins assemble into a common fibrillar structure; however, they do so through different pathways.
Amyloid diseases comprise a diverse group of conditions that are characterized by conformational conversion of soluble proteins into insoluble amyloid fibrils, which deposit in tissues such as the heart, liver, spleen, and brain [1] . While amyloid proteins differ from disease to disease, and differ vastly in size and sequence, the structure of all amyloid fibrils are strikingly similar [2] . All amyloid fibrils appear to be straight, unbranched fibers with a diameter of about 100 Å that stain with Congo Red, and exhibit redgreen birefringence. The X-ray fiber diffraction patterns of all amyloid fibrils contain reflections that are characteristic of cross-b structure. In fact, a single model structure can fit the X-ray fiber diffraction patterns produced by amyloid fibrils derived from a diverse group of amyloid proteins [3] . This common structure of the amyloid protofiliament is composed of a number of b sheets twisting around a common helical axis, where the hydrogen bonding direction is parallel to the common helical axis [3] .
The ability of a diverse group of proteins to fold into a common fibrillar structure has prompted the hypothesis that many, if not all, proteins can be induced to form amyloid fibrils [4] . Proteins and peptides that form amyloid can be separated into two classes based on the structure of their native non-amyloid state. In the first class are proteins that are folded, globular, and soluble; proteins that are unstructured or possess marginally stable structure under native conditions comprise the second class. The folded class of amyloidogenic proteins can be induced to form amyloid fibrils by subjecting them to mildly denaturing conditions where an aggregation-prone folding intermediate is populated. The proteins in this class include transthyretin, lysozyme, variable domain of immunoglobulin light chains and others [5, 6] . Amyloid proteins and peptides that are unfolded or marginally folded under native conditions include the Alzheimer amyloid peptide (Ab), islet amyloid polypeptide (IAPP), a-synuclein, and tau [6] .
While it has been established that all amyloid fibrils possess a common core structure, it is not known whether the kinetic process of fibrillogenesis is also conserved. In this paper, we examine the fibrillogenesis of a peptide derived from residues 195-213 of the human prion protein, PrP (195 -213). Many mutations that cause GerstmannSträussler -Scheinker disease (GSS) and familial Creutzfeldt -Jakob disease (fCJD) are clustered in . In addition, this peptide has been shown previously to form amyloid fibrils [7] . We have used a variety of biophysical techniques including fluorescence resonance energy transfer (FRET) methods that we have applied previously to study fibrillogenesis of Ab [8] . We find that, unlike Ab, fibrillogenesis of ) is an all-or-none process without appreciable population of small multimeric intermediates. Therefore, even though the core structures of all amyloid fibrils are highly similar, the fibrillogenesis pathways of individual amyloids are not conserved.
M A T E R I A L S A N D M E T H O D S
Peptide synthesis and fluorescent labeling of peptides Peptide derivatives of PrP (195-213) ( Fig. 1) were synthesized using solid phase chemistry on the Perseptive Biosystems 9050 peptide synthesizer. 9-Fluorenylmethoxy carbonyl (FMOC) was used as the a-amino protecting group for amino acids, and O-(7-azabenzotriazol-1-yl)-1,1,3,3,-tetramethyluronium hexafluorophosphate (HATU), PerSeptive Biosystems, GmbH, Hamburg, Germany, catalogue no. GENO76523, lot no. 217419, was used as activator of carboxylic group. The peptides were cleaved from the resin (PAL-PEG-PS, PerSeptive Biosystems, Warrington, UK, catalogue no.; Gen913383, lot no. 9812005) with a trifluoroacetic acid/anisole/triispropylsilane 90 : 8 : 2 (v/v) mixture. Synthesis products were precipitated with ice-cold ether, recovered by centrifigation, washed three times in ether, dissolved in 6.5 M guanidine/HCl, and purified by RP-HPLC on a C 18 column. Peptide identity was confirmed by mass spectrometry.
Prior to fluorescent labeling, a glycine residue was added to the N-terminus of PrP Purified peptides were lyophilized, and dissolved in 10% hexafluoroisopropanol (HFIP) and the peptide concentration was determined via tryptophan absorbance at 281 nm with an extinction coefficient [9] 
Fluorescence spectroscopy
Fluorescence intensity was measured at room temperature using a Photon Technology International QM-1 fluorescence spectrophotometer equipped with excitation intensity correction. Emission spectra from 300 nm to 550 nm were collected (ex ¼ 281 nm, 0.1-1 second : nm 21 , bandpass ¼ 2 nm for excitation and emission). Cuvettes with 1-cm path lengths and volumes of either 0.5 mL or 3 mL were used. Samples were prepared at 1 : 1 ratio (w/w) of and . To obtain the desired concentrations, appropriate amounts of peptide stock solutions in 10% HFIP were mixed, lyophilized, and dissolved in the appropriate buffer on the day of the experiment.
Turbidity measurement
To monitor aggregation, the UV absorbance at 400 nm of was measured with a Milton Roy Spectronic 300 Array UV spectrophotometer.
Circular dichroism
Far-UV circular dichroism spectra were recorded on an Aviv circular dichroism spectrometer model 62DS (Lakewood, NJ, USA) at 25 8C using quartz cells with a path length of 0.1 cm. Spectra were obtained from 195 nm to 260 nm, with a 1.0-nm step, 1.0-nm bandwidth, and 4-s collection time per step. The experimental data were expressed as mean residue ellipticity (u) (deg : cm 2 : dmol 21 ).
Electron microscopy
Samples were placed on carbon-coated pioloform grid, blotted to remove excess sample and negatively stained with 1% (w/v) phosphotungstic acid, pH 7. The peptide assemblies were observed in a Hitachi 7000 operated with an accelerating voltage of 75 kV and images were recorded on film.
R E S U L T S PrP (195 -213) peptide displays minor helical propensity
The structure of recombinant prion proteins has been solved by NMR in three species: mouse 23 -231 [11] , hamster 29 -231 [12] , and human 23 -230 [13] . As shown in Fig. 1 , 14 residues in C-terminal region of the human PrP (195 -213) peptide correspond to the third helix of the NMR structure of PrP [13] . Helical propensity of residues 195-213 could also be predicted (data not shown) from a modified form of Lifson -Roig helix-coil theory, and helix propagation parameters measured in alanine-based peptides [14, 15] . Circular dichroism of PrP (195-213) in NaCl/P i (120 mM NaCl, 10 mM phosphate buffer) at pH 7.0 revealed that the peptide in solution was predominantly unstructured (displaying a strong negative CD band at 198 nm), but also possessed a small amount of helical structure (displaying a weak negative band around 222 nm). In the presence of the helix-promoting agent HFIP 10%, helical structure of the peptide was more pronounced, as shown by characteristic minima at 208 nm and 222 nm (Fig. 2 ).
Self-association of PrP (195 -213) monitored by FRET
We developed a sensitive method to monitor self-association of PrP (195-213) peptide monomers based on FRET. This technique has been applied by us [8] and others [16] to examine the aggregation of amyloid Ab peptide [8] . In this method, donor and acceptor fluorophores are present on separate monomeric peptides and intermolecular energy transfer reports on the spatial proximity resulting from association or aggregation. Notably, FRET is sensitive to the association of peptide monomers in small soluble oligomers such as dimers and tetramers [8, 16] that would not be detectable by other techniques, such as turbidity (see below).
In these experiments, aliquots of PrP (195-213) were labeled with the FRET donor tryptophan and other aliquots were labeled with the FRET acceptor AEDANS. Donorlabeled peptide, Trp-PrP (195-213) (0.125 mg : mL 21 ), was mixed with acceptor-labeled peptide, AEDANS-PrP (195-213) (0.125 mg : mL 21 ) at various pH values between 1.6 and 7.1. The fluorescence emission spectra of the peptide preparations were measured using an excitation wavelength of 281 nm, which causes significant excitation of Trp fluorophores but only slight excitation of AEDANS fluorophores. The emission spectra of the peptide samples at different pH indicated that lowering of pH from 7.1 to 1.6 was associated with two phenomena: quenching of Trp emission and increased sensitization of AEDANS emission (Fig. 3) , thus demonstrating hallmarks of FRET. Therefore, it appears that low pH triggers the association of PrP (195-213) peptides into oligomers or aggregates at lower pH.
The following procedure was used to obtain a quantitative measure of the degree of association. AEDANS intensities from 425 to 525 nm were integrated and this value was expressed as a ratio vs. the integrated intensities of Trp from 300 to 400 nm. The degree of association is directly proportional to this acceptor/donor ratio. The acceptor/ donor ratios calculated from Fig. 3 were plotted as a function of pH and a sigmoidal titration curve was obtained (Fig. 4A) . The midpoint of the pH titration occurred at pH 3.90, which is very close to the pK a of the sidechains of Asp or Glu [17] . This suggests that neutralization of Asp and Glu sidechain carboxyl groups of PrP (195-213) can trigger self-association of the peptides.
Aggregation of PrP (195 -213) is cooperative and small oligomers are not populated at equilibrium
As mentioned above, the FRET method for assessing the self-association tendency of PrP (195 -213) is capable of detecting the formation of small oligomers as well as the formation of large aggregates. Measurement of turbidity is another method for assessing peptide aggregation [18] ; however, this method will not detect the formation of small oligomers. FRET and turbidity measurements, used in tandem, can evaluate whether the aggregation process is allor-none, or whether oligomeric intermediates are populated during the course of aggregation.
The pH-dependent changes in turbidity of PrP (195-213) were monitored over the range pH 1.6 -7.1 and correlated with FRET measurements (Fig. 4A) . The pH-titration curves obtained from both FRET and turbidity measurements were superimposable. This observation suggests that PrP (195 -213) aggregates that form as the pH is lowered are predominantly large, and oppose the formation of small oligomers ) in 120 mM NaCl, 2 mM sodium phosphate, and 2 mM sodium citrate at various pH values between 1.6 and 7.1. The fluorescence emission spectra of the peptide preparations were measured using an excitation wavelength of 281 nm, pH 7.09 (X), pH 6.12 (W), that would contribute to FRET but not to turbidity. Thus, the acid-induced aggregation of PrP (195 -213) appears to be an all-or-none reaction in which oligomeric intermediates are not populated. To investigate whether small oligomeric states of PrP (195 -213) are populated transiently, the time course of aggregation/association at pH 2.0 was monitored using both FRET and turbidity measurements. The pH 2.0 point was chosen because both FRET and turbidity values were maximal and on the upper plateau region of the pH titration curves. The kinetic curves obtained from the FRET and turbidity measurements both possessed a lag time of 6 h and were superimposable at pH 2.0 (Fig. 4B) . Furthermore, the correlation between FRET and turbidity measurements was highly statistically significant (r ¼ 0.988, P ¼ 0.0001). This indicates that any oligomeric intermediates that form prior to the formation of large aggregates are very shortlived and rapidly go on to form large aggregates, consistent with an all-or-none mechanism.
To confirm that soluble oligomeric forms of PrP (195 -213) are not populated under equilibrium conditions, FRET measurements were taken on an aggregated sample of peptide before and after centrifugation at 16 000 g (Fig. 5) . In the uncentrifuged aggregate suspension, a prominent FRET signal was observed, indicative of peptide-peptide association (see above). In the centrifuged supernatant, the acceptor/donor ratio was 0.215, identical to the ratio of unassociated peptides prior to aggregation (Fig. 4B) . Thus, all of the soluble peptide in the aggregated sample appeared monomeric and not oligomeric.
It is possible to calculate the critical concentration for PrP (195 -213) polymerization by determining the concentration of monomeric peptide in the centrifuged supernatant. Our estimate for this number is 18 mM. For the sake of comparison, the critical concentration for polymerization of the Alzheimer amyloid peptide (Ab40) is estimated to be between 10 and 40 mM [18] .
Formation of b structure accompanies aggregation of PrP (195 -213) peptide
Changes in the secondary structure of during the time course of aggregation at pH 2.6 was assessed by CD spectroscopy. The CD spectrum of PrP (195 -213) prior to aggregation possessed a minimum at 201 nm and a small shoulder at 220 nm (Fig. 6 ). This spectrum is indicative of a predominantly unstructured peptide that may also possess a small amount of a helical structure. After aggregation, the CD spectrum possessed a single minimum at 218 nm (Fig. 6) , typical of b structure.
Aggregates from PrP (195 -213) peptide are fibrillar
Freshly prepared mixtures of Trp-and AEDANS-PrP (195 -213), which were shown to be nonaggregated by both FRET and turbidity measurements, were examined by negative stain electron microscopy. Electron micrographs of these preparations contained some insoluble material with flexible fibrous structure; however, their morphology was different from typical amyloid fibrils (Fig. 7A) . On the other hand, preparations of Trp-and AEDANS-PrP (195 -213) that were aggregated contained many long amyloid fibrils < 100 Å in diameter and several mm in length; helical twisting and protofilament substructure was observed (Fig. 7B) .
D I S C U S S I O N
We have shown, using FRET and turbidity measurements in tandem, that PrP (195 -213) aggregation is a highly cooperative process that apparently occurs by an all-ornone mechanism, without appreciable population of small multimeric intermediates. As the operational distance limitation of FRET is approximately 40 Å , this method could be conceivably applied to larger PrP fragments, e.g. PrP (90 -231), or even to intact PrP.
The pH dependence of aggregate-fibril formation has an apparent pK a of 3.9, suggesting that the assembly process is promoted by protonation of the sidechain carboxyl groups of Asp and Glu residues in PrP (195 -213). The effect of pH on PrP and PrP fragments has been well studied. It is thought that PrP conversion in vivo occurs in the acidic environment of the endosomal -lysosomal system [19] [20] [21] [22] . Recombinant forms of human PrP (90-231) [23] , human PrP (91-231) [24] , and mouse PrP (121-231) [25] form an equilibrium folding intermediate at low pH in the presence of either 1 M guanidine hydrochloride or 3.5 M urea. The equilibrium intermediate of human PrP (91 -231) with disulfide bonds intact has a tendency to aggregate [24] . The pH-induced conversion of human PrP (90-231) and mouse PrP (121 -231) from the native state to the equilibrium folding intermediate occur with an apparent pK a of 5.1 [23] and 4.5 [25] , respectively. These apparent pK a values suggest the involvement of either acidic residues (i.e. Asp and Glu) or histidines. Electrostatic calculations, based on the solution structures of mouse PrP (121-231) and Syrian hamster PrP (90-231), have suggested that protonation of the following acidic residues, which are listed in rank order, causes the greatest destabilization of the native state of PrP and may facilitate the formation of the equilibrium folding intermediate: E196, D178, D202, E152, D144, D147, E146, and E211 [26] . Calculations also implicate the involvement of H96 and H111 in aggregation of PrP [26] . In the present study, PrP (195-213) also possess the property of forming b structure and amyloid fibrils at lower pH. PrP (195 -213) contains E196, E200, D202, E207, and E211, which includes three of the acidic amino acids listed above as most important in the pH transition of recombinant PrP C to a b sheet form.
What is the mechanism by which protonation of acidic residues promotes aggregation-fibrillogenesis in PrP (195 -213)? Two scenarios might apply. First, peptide aggregation may be promoted by isoelectric precipitation that occurs when the pH is lowered to the peptide's isoelectric point where net charge is zero. Second, aggregation may be prevented by the repulsion of acidic sidechains at higher pH, in NaCl/P i , pH 2.6 before (X) and after (W) aggregation. and neutralization of these sidechains at lower pH could therefore promote fibrillogenesis. PrP (195-213) peptide contains four Glu, one Asp, one Lys, one Arg, and a free a amino group at the N-terminus (the C-terminus is amidated). Based on the typical pK a values of the ionizable groups present, the isoelectric point of the peptide would probably be between 3 and 4. At pH2 the peptide would have a net charge of 13. As fibrils form readily at pH2 (Fig. 7) , this reduces the likelihood of isoelectric precipitation being the cause of pH-dependent aggregation ( Figs 4A and 7) . Thus, the second scenario, that fibrillogenesis at higher pH is prevented by repulsion of acidic sidechains, provides a more plausible explanation for our findings. This explanation implies that the repulsion of acidic sidechains (above pH 4) is more disruptive to aggregation-fibrillogenesis than the repulsion of basic sidechains (below pH 4). Perhaps there is a larger intermolecular separation distance between positive charges in the three-dimensional structure of the fibril compared to the separation distance between the negative charges.
The process of fibril formation by PrP (195 -213) exhibited a well-defined lag phase (Fig. 4B) . Two nonexclusive models have been proposed for the conversion of PrP C to PrP Sc : seeded polymerization and template-assistance. A lag phase is a prominent feature of both proposed mechanisms. In the seeded polymerization model, PrP
Sc is considered to be an aggregate and the aggregation process is believed to induce a transformation of PrP C to the b-structured amyloid polymer. Oligomerization of a number of PrP molecules represents the formation of a nucleus or seed and is proposed to be a slow process that accounts for the lag phase [27] [28] [29] . The template-assistance model proposes that the lag phase is caused by the presence of a large kinetic barrier to the conversion of monomeric PrP C to monomeric PrP Sc . In this model, a single PrP Sc molecule is proposed to act as a template that reduces the kinetic barrier and catalyzes conversion of monomeric PrP C to PrP Sc [30, 31] . From the results of this study, we conjecture that the lag phase observed with fibrillogenesis of PrP (195 -213) is a result of the slow formation of an oligomeric nucleus for the following reasons. Unlike PrP C , monomeric PrP (195 -213) contains at most a very small amount of helical structure with marginal stability. Folding and unfolding of small peptides containing single helices occurs relatively rapidly [32] [33] [34] ; consequently, conversion of PrP (195-213) from its partially helical state to a monomeric state, where the peptide possesses dihedral angles in the b sheet region of the Ramachandran plot, is also expected to occur rapidly. Furthermore, because of the small size of the PrP (195 -213) peptide, it is unlikely that the molecule can form a monomeric H-bonded b sheet structure that would be equivalent to a monomeric PrP Sc molecule. Finally, our finding that aggregation-fibrillogenesis of this peptide follows an all-or-none process indicates that small oligomers are unstable. From this evidence, we surmise that the observed lag phase reflects the slow formation of oligomeric nuclei. Once formed, the nuclei rapidly grow into amyloid fibrils.
The all-or-none fibrillogenesis mechanism of PrP (195 -213) differs markedly from the kinetic mechanism of other amyloid. Fibrillogenesis of the Alzheimer Ab peptide appears to proceed through a number of oligomeric intermediates that are transiently populated for time periods ranging from minutes to hours. Prior to fibril formation, Ab associates into small oligomers ranging from dimers to tetramers [8, 16] . Other intermediates of Ab fibrillogenesis include soluble spherical aggregates [8, [35] [36] [37] and protofibrils [37, 38] . Transient formation of spherical aggregates has also been observed during fibrillogenesis of a-synuclein [39] and IAPP [40] . This variation in whether intermediate states are stably populated during fibrillogenesis demonstrates that different amyloid proteins utilize different pathways to arrive at the same core structure.
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